Save time and get answers to complex questions with AI chat
Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Novartis patent term dabrafenib?Drugpatentwatch trametinib?Drugpatentwatch market analysis industry today?Atorvastatin side effects heart palpitations?
See the DrugPatentWatch profile for Xolair
If you mean the FDA approval in the United States: Xolair (omalizumab) was approved on June 26, 2003, for moderate-to-severe persistent allergic asthma not well controlled with inhaled corticosteroids. If you meant a different country or a later indication, tell me and I can provide that date as well.
Other Questions About Xolair :